We are live on ! Find out more
VLKIM

Van Lanschot Kempen Investment Management Portfolio holdings

AUM $13.1B
1-Year Est. Return 19.56%
This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+19.56%
3 Year Est. Return
+75.92%
5 Year Est. Return
+98.44%
10 Year Est. Return
+233.43%
AUM
$2.49B
AUM Growth
-$300M
Cap. Flow
-$189M
Cap. Flow %
-7.62%
Top 10 Hldgs %
25.14%
Holding
226
New
20
Increased
47
Reduced
122
Closed
18

Top Buys

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$49.1M
2
TROX icon
Tronox
TROX
+$29.1M
3
FERG icon
Ferguson
FERG
+$28.6M
4
ALV icon
Autoliv
ALV
+$20.5M
5
EHAB
Enhabit
EHAB
+$19.7M

Sector Composition

Rank Sector Weight
1 Real Estate 16.79%
2 Technology 14.11%
3 Financials 13.24%
4 Consumer Discretionary 12.57%
5 Industrials 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HR
226
DELISTED
Healthcare Realty Trust Incorporated
HR
-517,041
Closed -$14.1M

Similar funds

Van Lanschot Kempen Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Van Lanschot Kempen Investment Management held 226 positions worth $2.49B, down 11% from $2.78B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Van Lanschot Kempen Investment Management withdrew a net $189M in Q3 2022, closing 18 positions and reducing 122 holdings. Its most notable exit was Meridian Bioscience Inc, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

Against the trend, Van Lanschot Kempen Investment Management opened a new position in QuidelOrtho worth $39.2M.

  • Van Lanschot Kempen Investment Management's largest Q3 2022 buy was QuidelOrtho: 549,045 shares worth $39.2M.
  • Van Lanschot Kempen Investment Management added most to American Homes 4 Rent in Q3 2022, an estimated $10.5M increase.
  • Van Lanschot Kempen Investment Management's biggest Q3 2022 reduction was First Solar, cutting an estimated $52.4M.
  • Van Lanschot Kempen Investment Management fully exited Meridian Bioscience Inc in Q3 2022, selling an estimated $40.6M.
  • Van Lanschot Kempen Investment Management's ten largest holdings make up 25% of its $2.49B portfolio in Q3 2022.
  • Van Lanschot Kempen Investment Management opened 20 new positions and closed 18 in Q3 2022.
  • Van Lanschot Kempen Investment Management's portfolio value fell 11% quarter-over-quarter to $2.49B.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.